Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3927]
News [11440]
Articles [47]
Editorials [10]
Conferences [200]
elearning [4]
The importance of area-based cancer research
Dr Bhawna Sirohi - BALCO Medical Centre, Raipur, India
The importance of area-based cancer research ( Dr Bhawna Sirohi - BALCO Medical Centre, Raipur, India )
7 Oct 2022
Impact of the Choosing Wisely conference in Nepal
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Impact of the Choosing Wisely conference in Nepal ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
7 Oct 2022
The cancer access partnership
Prof Richard Sullivan and Emily Kobayashi
The cancer access partnership ( Prof Richard Sullivan and Emily Kobayashi )
6 Oct 2022
The Max foundation: Its mission and contribution to increasing access to cancer...
Prof Richard Sullivan and Pat Garcia-Gonzalez
The Max foundation: Its mission and contribution to increasing access to cancer medicine ( Prof Richard Sullivan and Pat Garcia-Gonzalez )
6 Oct 2022
Pursuing global equity in access to cancer drugs lessons learned from the HIV...
Prof Richard Sullivan and Dr Megan O’Brien
Pursuing global equity in access to cancer drugs lessons learned from the HIV epidemic ( Prof Richard Sullivan and Dr Megan O’Brien )
6 Oct 2022
ESMO 2022: Lung roundup
Dr Luis Raez - Memorial Cancer Institute, Miami, USA
ESMO 2022: Lung roundup ( Dr Luis Raez - Memorial Cancer Institute, Miami, USA )
4 Oct 2022
Xevinapant plus standard of care chemoradiotherapy improved 5 year OS for...
Prof Jean Bourhis - University Hospital of Lausanne, Lausanne, Switzerland
Xevinapant plus standard of care chemoradiotherapy improved 5 year OS for unresected LA SCCHN ( Prof Jean Bourhis - University Hospital of Lausanne, Lausanne, Switzerland )
27 Sep 2022
Abemaciclib plus trastuzumab fulvestrant increased OS for HR+, HER2+ advanced...
Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA
Abemaciclib plus trastuzumab fulvestrant increased OS for HR+, HER2+ advanced breast cancer ( Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA )
21 Sep 2022
Cancer survivors' stories: An African perspective
Dr Zainab Shinkafi-Bagudu - Founder of the Medicaid Cancer Foundation
Cancer survivors' stories: An African perspective ( Dr Zainab Shinkafi-Bagudu - Founder of the Medicaid Cancer Foundation )
15 Sep 2022
ESMO 2022: Breast and ovarian trial analysis
Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2022: Breast and ovarian trial analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
14 Sep 2022
ERMES study suggests a strategy of de-escalation with only cetuximab in first...
Dr Armando Orlandi - Agostino Gemelli University Polyclinic, Rome, Italy
ERMES study suggests a strategy of de-escalation with only cetuximab in first line therapy for RAS and BRAF wild type mCRC ( Dr Armando Orlandi - Agostino Gemelli University Polyclinic, Rome, Italy )
14 Sep 2022
Neoadjuvant immunotherapy improves outlook in high-risk melanoma
Dr Sapna Patel - MD Anderson Cancer Center, Houston, USA
Neoadjuvant immunotherapy improves outlook in high-risk melanoma ( Dr Sapna Patel - MD Anderson Cancer Center, Houston, USA )
14 Sep 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation